Free Trial

Evoke (LON:EVOK) Shares Up 17.2% - Time to Buy?

Evoke logo with Consumer Cyclical background

Evoke plc (LON:EVOK - Get Free Report)'s share price was up 17.2% on Wednesday . The stock traded as high as GBX 45.90 ($0.60) and last traded at GBX 44.30 ($0.58). Approximately 3,500,189 shares were traded during trading, an increase of 35% from the average daily volume of 2,588,063 shares. The stock had previously closed at GBX 37.80 ($0.49).

Analysts Set New Price Targets

Separately, Jefferies Financial Group reissued a "buy" rating and issued a GBX 140 ($1.83) price target on shares of Evoke in a research report on Monday, December 16th.

Get Our Latest Stock Analysis on Evoke

Evoke Price Performance

The firm has a 50 day simple moving average of GBX 62.59 and a 200-day simple moving average of GBX 62.11. The stock has a market capitalization of £212.29 million, a price-to-earnings ratio of -1.19 and a beta of 0.84.

Evoke (LON:EVOK - Get Free Report) last announced its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) earnings per share (EPS) for the quarter. Evoke had a negative return on equity of 517.98% and a negative net margin of 8.50%. On average, sell-side analysts forecast that Evoke plc will post 12.7648305 earnings per share for the current fiscal year.

Insider Transactions at Evoke

In related news, insider Jonathan (Jon) Mendelsohn acquired 200,000 shares of the stock in a transaction on Monday, March 31st. The stock was purchased at an average price of GBX 48 ($0.63) per share, for a total transaction of £96,000 ($125,605.13). Also, insider Andrea Gisle Joosen acquired 14,572 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average price of GBX 70 ($0.92) per share, with a total value of £10,200.40 ($13,346.07). 27.00% of the stock is owned by company insiders.

Evoke Company Profile

(Get Free Report)

Featured Stories

Should You Invest $1,000 in Evoke Right Now?

Before you consider Evoke, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Evoke wasn't on the list.

While Evoke currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Blowout Earnings Winners That Could Soar Even Higher
5 Stocks You’ve Never Heard Of That I’m Buying Nonstop in 2025
3 Sectors With Massive Momentum You Can’t Afford to Miss

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines